mTOR/HDAC6-IN-1 is a dual inhibitor of mammalian target of rapamycin (mTOR) and histone deacetylase 6 (HDAC6), with IC50 values of 133.7 nM and 56 nM, respectively; it induces significant autophagy and apoptosis, inhibits cell migration, and shows potential for the research of triple-negative breast cancer (TNBC).